|
|
|
市場調查報告書
中國的製藥產業大50公司:2011年∼2012年
Research Report on Top 50 Companies of China's Pharmaceutical Industry, 2011-2012
|
中國的製藥產業大50公司:2011年∼2012年 是由出版商China Research and Intelligence在2011年11月所出版的。
這份英文市場調查報告書包含Pages: 65 價格從美金2800起跳。
中國製藥產業的產量，在2000年為1,781億4千萬人民幣，但2010年便增加到1兆1,993億8千萬人民幣，年複合成長率達到20%。中國在2010年末的現在，擁有7,000以上家製藥企業。
本報告提供中國50家龍頭製藥業者的相關調查分析，彙整企業簡介，產業營運，發展策略等相關分析，為您概述為以下內容。
第1章 Harbin Pharmaceutical Group Holding CO., LTD
第2章 CSPC Pharmaceutical Group Limited
第3章 Shanghai Pharmaceuticals Holding Co., Ltd
第4章 Yangtze River Pharmaceutical Group
第5章 Jilin Xiuzheng Pharmaceutical Group
第6章 廣州 Pharmaceutical Holdings Limited
第7章 Huabei Pharmaceutical Group
第8章 Buchang Group
第9章 天津 Kingyork Group CO., LTD
第10章 Bayer Healthcare CO., LTD
第11章 天津 Pharmaceutical Group
第12章 Northeast Pharmaceutical Group CO., LTD
第13章 北京 Tong Ren Tang Group Co., Ltd.
第14章 Pfizer Inc.
第15章 北京 Pharmaceutical Group CO., LTD
第16章 Tasly Group
第17章 Qilu Pharmaceutical CO., LTD
第18章 China National Biotec Group
第19章 The United Laboratories International Holdings Co., Ltd.
第20章 Huadong Pharmaceutical Co., Ltd
第21章 Novonordisk Pharmaceutical Ltd
第22章 Xian-Janssen Pharmaceutical Ltd
第23章 Sichuan Kelun Pharmaceutical CO., LTD
第24章 Zhejiang Medicine Co., Ltd
第25章 Jiangxi Jiminkexin Group Co., Ltd
第26章 Chongqing Taiji Industry (Group) Co., Ltd
第27章 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd
第28章 Reyoung Pharmaceutical Co., Ltd
第29章 Furen Medicine Group
第30章 Shanghai Fosun Pharmaceutical (Group) Co., Ltd
第31章 Shanghai Roche Pharmaceutical Co., Ltd
第32章 深圳 Hepalink Pharmaceutical Co., Ltd
第33章 Jiangsu Hengrui Medicine Co., Ltd
第34章 Yunnan Baiyao Group Co., Ltd
第35章 Zhejiang NHU Company Ltd
第36章 Lunan Pharmaceutical Group Co., Ltd.
第37章 Guangdong Kang Mei Pharmaceutical Co., Ltd
第38章 Henan Topfond Pharmaceutical Co., Ltd
第39章 AstraZeneca Pharmaceutical Co., Ltd.
第40章 Shandong Xinhua Pharmaceutical Group Co., Ltd
第41章 Jiangsu Xiansheng Pharmaceutical Co., Ltd
第42章 北京 Novartis Pharmaceutical Co., Ltd
第43章 Jiangsu Kanion Pharmaceutical Co Ltd
第44章 Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd
第45章 Shanxi Bicon Pharmaceutical Co., Ltd
第46章 Livzon Pharmaceutical Group Inc.
第47章 Jiangsu Hanson Pharmaceutical Co., Ltd
第48章 Zhejiang Conba Pharmaceutical Co., Ltd
第49章 Shineway Pharmaceutical Group
第50章 Shouguang Fukang Pharmaceutical Co., Ltd
圖表
Description
Since 2006, the proportion of China pharmaceutical industry output in GDP has remained stable. In the past five years, the proportion fell slightly in 2007, while in other years it kept a growth trend. Especially from 2008H2 to 2009H1, though the global economic development environment generally slowed down, China pharmaceutical industry's performance was still gratifying, showing great development potential. China pharmaceutical industry output growth from CNY 178.14 billion in 2000 to CNY 1,193.38 billion in 2010, with a compound annual growth rate of more than 20%. From January to September 2011, the Chinese medicine industry achieved an output of CNY 1,059.10 billion, increased by 29.1% YOY.
By the end of 2010, there were more than 7,000 pharmaceutical enterprises in China, but the industry concentration was very low. In November 2010, the Chinese Government issued the Guidance on Accelerating Structure Adjustment in Medical Industry, which clearly states that the Chinese Government will support the innovation and technology upgrading of the pharmaceutical industry, promote the M & A and improve industry concentration.
This report analyses the 2010 sales of China's pharmaceutical industry's top 50 companies, including chemical medicine, traditional Chinese medicine, bio-pharmaceuticals and other industries.
By reading this report, readers can get the following information:
- Major domestic pharmaceutical manufacturing enterprises
- Major foreign-funded pharmaceutical enterprises in China
- Major listed pharmaceutical manufacturing enterprises in China
- The operation of China's main pharmaceutical manufacturing enterprises
The following persons are recommended to purchase this report:
- Medicine manufacturing enterprises
- Pharmaceutical trading enterprises
- Investors concern China pharmaceutical industry
- Industry research institutes focus on China pharmaceutical industry
Table of Contents
1 Harbin Pharmaceutical Group Holding CO., LTD
- 1.1 Enterprise Profiles
- 1.2 Business Operations
- 1.3 Development Strategies of Harbin Pharmaceutical Group
2 CSPC Pharmaceutical Group Limited
- 2.1 Enterprise Profiles
- 2.2 Business Operations
- 2.3 Development Strategies of CSPC Pharmaceutical Group
3 Shanghai Pharmaceuticals Holding Co., Ltd
- 3.1 Enterprise Profiles
- 3.2 Business Operations
4 Yangtze River Pharmaceutical Group
- 4.1 Enterprise Profiles
- 4.2 Business Operations
- 4.3 Development Strategy
5 Jilin Xiuzheng Pharmaceutical Group
- 5.1 Enterprise Profiles
- 5.2 Business Operations
6 Guangzhou Pharmaceutical Holdings Limited
- 6.1 Enterprise Profiles
- 6.2 Business Operations
7 Huabei Pharmaceutical Group
- 7.1 Enterprise Profiles
- 7.2 Business Operations
8 Buchang Group
- 8.1 Enterprise Profiles
- 8.2 Business Operations
9 Tianjin Kingyork Group CO., LTD
10 Bayer Healthcare CO., LTD
11 Tianjin Pharmaceutical Group
12 Northeast Pharmaceutical Group CO., LTD
13 Beijing Tong Ren Tang Group Co., Ltd.
14 Pfizer Inc.
15 Beijing Pharmaceutical Group CO., LTD
16 Tasly Group
17 Qilu Pharmaceutical CO., LTD
18 China National Biotec Group
19 The United Laboratories International Holdings Co., Ltd.
20 Huadong Pharmaceutical Co., Ltd
21 Novonordisk Pharmaceutical Ltd
22 Xian-Janssen Pharmaceutical Ltd
23Sichuan Kelun Pharmaceutical CO., LTD
24 Zhejiang Medicine Co., Ltd
25Jiangxi Jiminkexin Group Co., Ltd
26 Chongqing Taiji Industry (Group) Co., Ltd
27 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd
28 Reyoung Pharmaceutical Co., Ltd
29 Furen Medicine Group
30 Shanghai Fosun Pharmaceutical (Group) Co., Ltd
31 Shanghai Roche Pharmaceutical Co., Ltd
32 Shenzhen Hepalink Pharmaceutical Co., Ltd
33Jiangsu Hengrui Medicine Co., Ltd
34 Yunnan Baiyao Group Co., Ltd
35 Zhejiang NHU Company Ltd
36 Lunan Pharmaceutical Group Co., Ltd.
37 Guangdong Kang Mei Pharmaceutical Co., Ltd
38 Henan Topfond Pharmaceutical Co., Ltd
39 AstraZeneca Pharmaceutical Co., Ltd.
40 Shandong Xinhua Pharmaceutical Group Co., Ltd
41 Jiangsu Xiansheng Pharmaceutical Co., Ltd
42 Beijing Novartis Pharmaceutical Co., Ltd
43 Jiangsu Kanion Pharmaceutical Co Ltd
44 Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd
45 Shanxi Bicon Pharmaceutical Co., Ltd
46 Livzon Pharmaceutical Group Inc.
47 Jiangsu Hanson Pharmaceutical Co., Ltd
48 Zhejiang Conba Pharmaceutical Co., Ltd
49 Shineway Pharmaceutical Group
50 Shouguang Fukang Pharmaceutical Co., Ltd
List of Charts
- Chart 2006-2010 Operating Income of Harbin Pharmaceutical Group
- Chart 2006-2010 Operations of Harbin Pharmaceutical Group Holding CO., LTD
- Chart 2006-2010 Sales of CSPC Pharmaceutical Group
- Chart 2006-2010 Operations of Shanghai Pharmaceuticals Holding Co., Ltd
- Chart 2006-2010 Sales of Jilin Xiuzheng Pharmaceutical Group
- Chart 2006-2010 Sales of Buchang Group
- Chart 2006-2010 Sales of Bayer Healthcare
- Chart 2006-2010 Sales of Xi'an-Janssen Pharmaceutical Co., Ltd
- Chart 2006-2010 Operations of China Resources Sanjiu Medical & Pharmaceutical Co., Ltd
- Chart 2006-2010 Sales of Shanghai Roche Pharmaceuticals Co., Ltd
|
 |
